Literature DB >> 12438861

Ossicular fixation caused by bone dust after saccus decompression surgery.

P Martinez Devesa1, L Michaels, A Wright.   

Abstract

HYPOTHESIS: To highlight the clinical and histologic features of ossicular fixation produced by bone dust during mastoid surgery.
BACKGROUND: Bone dust deposition in the middle ear may occur during temporal bone surgery, but the ossicular fixation that may result from it remains underreported.
METHODS: A case is reported of delayed conductive hearing loss after saccus decompression surgery resulting from ossicular fixation by bone dust deposition.
RESULTS: Six months after the initial surgery, the patient experienced a 45 dB conductive hearing loss. The findings on second-look tympanotomy were stapes fixation and round window niche occlusion by newly formed tissue. Histologic examination of the latter showed fibrosis and new bone formation in reaction to particles of bone dust. New bone formation is a frequent concomitant of fibrosis in the middle ear and is probably not a growth from the bone dust.
CONCLUSION: The use of high-speed drilling of bone in temporal bone surgery carries the risk of bone dust particle deposition in the middle ear. Measures are discussed that can be used to prevent this complication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438861     DOI: 10.1097/00129492-200211000-00023

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

1.  The Incidence of Early Postoperative Conductive Hearing Loss after Microvascular Decompression of Hemifacial Spasm.

Authors:  Tingting Ying; Parthasarathy Thirumala; Paul Gardner; Miguel Habeych; Donald Crammond; Jeffrey Balzer
Journal:  J Neurol Surg B Skull Base       Date:  2015-05-22

2.  Facial root entry/exit zone contact in microvascular decompression for hemifacial spasm: a historical control study.

Authors:  Xianxia Yan; Chengwen Ma; Junxiang Gu; Jianqiang Qu; Junjie Quan; Xi Zhang; Qin Song; Le Zhou
Journal:  Ann Transl Med       Date:  2021-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.